Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Monotherapy in Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sirolimus in Thrombocytopenia, sponsored by Peking University First Hospital. Started Jan 2025; status: recruiting.
02
Drugs
sirolimus
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT06722586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06722586.